Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
Pre-Tax Income
Valeo Pharma Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Valeo Pharma Inc
TSX:VPH
|
Pre-Tax Income
-CA$27.8m
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Pre-Tax Income
-$323m
|
CAGR 3-Years
38%
|
CAGR 5-Years
27%
|
CAGR 10-Years
13%
|
|
Theratechnologies Inc
TSX:TH
|
Pre-Tax Income
-$17.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-7%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Pre-Tax Income
-CA$22m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Spectral Medical Inc
TSX:EDT
|
Pre-Tax Income
-CA$15.5m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-3%
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Pre-Tax Income
$12.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
32%
|
CAGR 10-Years
-3%
|
See Also
What is Valeo Pharma Inc's Pre-Tax Income?
Pre-Tax Income
-27.8m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Pre-Tax Income amounts to -27.8m CAD.
What is Valeo Pharma Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-63%
Over the last year, the Pre-Tax Income growth was -3%. The average annual Pre-Tax Income growth rates for Valeo Pharma Inc have been -80% over the past three years , -63% over the past five years .